Jan. 14, 2014
(Nasdaq: PDII), today announced the launch of PD One
, a proprietary technology platform aimed at expanding relationships between pharmaceutical and life science manufacturers and health care providers. The subscription-based platform enables clients to extend personal and brand interactions with physicians through a secure, professional networking platform that features direct messaging and dynamic content. PDI also announced that it has contracted with a leading pharmaceutical company to provide PD One to select sales representatives across the U.S., while its own Interpace Diagnostics subsidiary will also launch the platform with its sales force.
"With PD One, pharmaceutical marketers have a new tool that bridges the gap between the direct sales model and digital marketing, creating an entirely new communication channel to more effectively engage with health care practitioners," said Nancy Lurker. "PD One provides pharmaceutical manufacturers with a communications platform that allows their sales force to offer unique, value-added services to better reach and engage physicians online."
provides authorized sales representatives the ability to share compliant, secure content and to interact directly with health care providers. Through the PD One platform, pharmaceutical and life science companies can deliver content, send and receive emails, conduct e-detailing, create and manage content on customized microsites, and respond to information and sample requests through a single interface.
The new platform complements PDI's award-winning companion site,
, a content-rich, multi-functional digital environment that receives more than 50,000 visits by medical professionals each month. With more than 400,000 verified physicians in its database,
offers continuing medical education (CME) from myCME.com and drug information from MPR. Both myCME and MPR are properties of partner, Haymarket Media, Inc.
also includes RSS newsfeeds from leading medical journals and sponsored banner advertisements, along with unique content and specialty therapeutic area pages.
"We developed PD One to transform how life science companies communicate with clinicians," said
, Chief Innovation Officer, Group DCA. "By leveraging the success of The
manufacturers can deliver targeted information and intellectually stimulating content to clinicians – when they want to receive it - within a highly networked, multifunctional digital environment."
"PD One unites PDI's strengths across the commercialization, sales and digital marketing spectrum," said
, General Manager, Group DCA. "With physicians increasingly turning to technology for information, PD One leverages the shift to mobile solutions to further empower both clinicians and manufacturers."
PDI is a leading health care commercialization company providing superior insight-driven, integrated multi-channel message delivery to established and emerging health care companies. The company is dedicated to enhancing engagement with health care practitioners and optimizing commercial investments for its clients by providing strategic flexibility, full product commercialization services, innovative multi-channel promotional solutions, and sales and marketing expertise.